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Obesity clearly has numerous adverse effects on cardiovascular disease (CVD) risk factors, 
including increasing levels of arterial pressure, which often leads to left ventricular hypertrophy, 
increasing blood glucose values, leading to metabolic syndrome and diabetes mellitus, worsening 
dyslipidemia, and increasing systemic inflammation. 1These risk factors increase the 
development of most CVD , including hypertension, heart failure, atrial fibrillation, and coronary 
heart disease (CHD), which increases the risk of acute myocardial infarction (AMI).1,2  Despite 
the clear increase in CVD risk factors associated with obesity, as well as an increase in most 
CVD, a strong “obesity paradox” has been demonstrated among patients with established CVD. 
In fact, overweight and obese patients with CVD generally have a better prognosis, at least short-
term and medium-term compared with their leaner counterparts with the same CVD.1,2 
 
We and others have reported a strong obesity paradox in patients with CHD.1,3-7.  In fact, in a 
recent meta-analysis of 89 studies in over 1.3 million patients with CHD, by far the largest of 
such studies, Wang and colleagues7 not only confirmed the previous findings but also added 
some unique insights.  For example, in their meta-analysis, the obesity paradox was evident 
during early follow-up even in severely obese patients, but this effect seems to disappear after 
approximately five years.  Additionally, patients who have CHD with moderate, Class II obesity 
(body mass index [BMI] ≥35kg/m2) or severe, Class III obesity (BMI ≥40 kg/m2) have a higher 
mortality during long-term follow-up.7,8 
 
In the present issue of Nutrition, Keller and colleagues9 utilize the nationwide database in 2014 
of AMI in Germany and demonstrate a strong obesity paradox (using International Classification 
of Diseases codes for obesity) regarding in-hospital mortality in almost 125,000 AMI elderly 
patients ≥70 years.  Although they showed the best in-hospital survival in elderly with AMI who 
were coded with mild obesity (Class I, BMI ≥30 kg/m2), even those with Class III obesity had a 
survival advantage compared with those elderly AMI patients in the database without an obesity 
code.  Although this study is plagued by relying on the coding of obesity, meaning that some 
obese may have not been coded as being obese and some overweight (BMI ≥25 kg/m2) could 
have been coded as obese, the results of Keller and colleagues confirmed our recent finding of an 
obesity paradox in patients hospitalized with pulmonary hypertension in a large nationwide 
database from the United States (US).10  Clearly, however, having height and weights to 
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accurately determine BMI or, even better having other parameters of body composition such as 
fat mass and lean mass amount and/or functionality would be preferable. 
 
In a prior study of AMI in-hospital mortality, Das et al11 demonstrated a U-shaped mortality 
curve in patients with ST-segment elevation AMI, with the highest mortality noted in the 
“normal-weight” group (BMI ≥18.5 kg/m2 and <25 kg/m2) followed by those with Class III 
obesity.  However, in their study, after adjusting for potential confounding factors, only the Class 
III obese patients appeared to have significantly higher in-hospital mortality.11,12  The major 
emphasis in their report was on Class III obesity patients, which represented 5.1% of their 
population.  However, recent statistics in the US indicate that nearly 8% of our population now 
meet the criteria of Class III severe or “morbid” obesity.13 Keller’s current report differed, 
however, and demonstrated lower mortality even in those with Class III obesity in elderly 
Germans with AMI compared to non-obese patients.9 However, the study did not address 
whether the non-obese patients were classified as overweight, normal-weight or underweight 
(BMI<18.5 kg/m2). Lower body weight, especially if resulting from unintentional weight loss, is 
typically an adverse risk factor in elderly populations portending a poor prognosis in a number a 
chronic diseases, especially in CVD14. Therefore the fact that thinner older patients likely 
represented a group with lower muscle mass and higher levels of frailty, could have clearly been 
a risk factor for early demise.14,15   
 
It is important to emphasize that describing the obesity paradox in the older AMI population or 
in any population, including those with CVD, is not a promotion of overweightness and obesity 
or a suggestion that weight gain is generally beneficial.  As reviewed earlier, obesity clearly 
increases CVD, and in fact, many of the obese with CVD may not have developed CVD in the 
first place had progressive weight gain during adulthood been avoided.    However, we have 
focused our emphasis on the intriguing fact that clinicians should probably be more concerned 
about the prognosis in their leaner or underweight patients with CVD, particularly those with low 
levels of cardiorespiratory fitness (CRF) and low levels of muscle mass, muscular strength and 
muscle functionality (i.e., sarcopenia).1,2,15-17 Additionally, substantial evidence emphasizes that 
fitness is more important than fatness for predicting prognosis, especially in older 
populations.1,2,14-17  Efforts to increase CRF, lean mass,  and muscle mass/muscular strength with 
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physical activity, aerobic exercise training, resistance training and diet may go a long way to 
reduce CVD, modify frailty and improve prognosis in those with established CVD, 18  
particularly in older patients.   
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